Senseonics Holdings Inc (SENS)
0.3206
0.00 (0.00%)
USD |
NYAM |
Nov 22, 13:33
Senseonics Holdings Total Assets (Quarterly): 96.33M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 96.33M |
| June 30, 2024 | 111.56M |
| March 31, 2024 | 126.52M |
| December 31, 2023 | 138.22M |
| September 30, 2023 | 154.06M |
| June 30, 2023 | 153.36M |
| March 31, 2023 | 158.53M |
| December 31, 2022 | 177.67M |
| September 30, 2022 | 182.67M |
| June 30, 2022 | 175.32M |
| March 31, 2022 | 188.10M |
| December 31, 2021 | 198.93M |
| September 30, 2021 | 219.62M |
| June 30, 2021 | 235.12M |
| March 31, 2021 | 195.95M |
| December 31, 2020 | 35.92M |
| September 30, 2020 | 44.06M |
| June 30, 2020 | 40.84M |
| March 31, 2020 | 35.27M |
| December 31, 2019 | 132.80M |
| Date | Value |
|---|---|
| September 30, 2019 | 167.05M |
| June 30, 2019 | 98.40M |
| March 31, 2019 | 129.40M |
| December 31, 2018 | 159.97M |
| September 30, 2018 | 183.33M |
| June 30, 2018 | 208.67M |
| March 31, 2018 | 77.82M |
| December 31, 2017 | 45.94M |
| September 30, 2017 | 60.14M |
| June 30, 2017 | 47.16M |
| March 31, 2017 | 16.23M |
| December 31, 2016 | 22.27M |
| September 30, 2016 | 28.01M |
| June 30, 2016 | 38.68M |
| March 31, 2016 | 39.28M |
| September 30, 2015 | 0.0018M |
| June 30, 2015 | 0.001M |
| March 31, 2015 | 0.0147M |
| December 31, 2014 | 0.0172M |
| September 30, 2014 | 0.0044M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
35.27M
Minimum
Mar 2020
235.12M
Maximum
Jun 2021
140.04M
Average
153.71M
Median
Total Assets (Quarterly) Benchmarks
| Abbott Laboratories | 74.36B |
| DexCom Inc | 6.354B |
| Baxter International Inc | 26.68B |
| Boston Scientific Corp | 38.08B |
| Perspective Therapeutics Inc | 391.15M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 113.51M |
| Shareholders Equity (Quarterly) | -17.18M |
| Debt to Equity Ratio | -3.133 |
| Current Ratio | 2.470 |
| Net Debt Paydown Yield | -1.54% |